Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Placenta ; 34(3): 222-30, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23306067

RESUMEN

INTRODUCTION: The first step in human implantation is the attraction of the blastocyst to the endometrium. We aimed to study attraction of the human blastocyst to the endometrium, and how this process is accomplished by chemokines secreted by the endometrium. MATERIALS AND METHODS: Blastocyst trophectoderm cells and other trophoblast lineage cells were subjected to attraction assays by IP-10 and other chemokines using transwell migration and chemotaxis assays. Chemokine expression and secretion were investigated using immunohistochemistry, ELISA, FACS analysis, and RT-PCR on material from flushing of the uterine cavity in endometrial biopsies. Chemokine receptor expression by blastocyst trophectoderm following PGD biopsy, trophectoderm derived from hES, placental villi, and other trophoblast lineage cells were characterized by the same methods. RESULTS: IP-10 dramatically attracted trophectoderm derived from hES cells and other lineages by interaction with CXCR3 chemokine receptors, as shown by both chemotaxis and transwell migration. High levels of IP-10 were detected throughout the menstrual cycle at flushing of the uterine cavity. Immunohistochemistry, FACS analysis, and RT-PCR of endometrial biopsy detected IP-10 in glandular and stromal cells of the endometrium. High levels of IP-10 were detected in condition medium of the endometrial stromal and glandular cells. Of all of the chemokine/chemokine receptor combinations examined, the IP-10/CXCR3 interaction was the only cytokine that was significantly elevated. DISCUSSION: While they await the wandering blastocyst, IP-10 is produced by many cells of the endometrium, but not by endometrial natural killer cells. CONCLUSION: Endometrial IP-10 may specifically attract human blastocyst trophectoderm cells early in implantation.


Asunto(s)
Quimiocina CXCL10/farmacología , Quimiotaxis/efectos de los fármacos , Ectodermo/efectos de los fármacos , Implantación del Embrión/fisiología , Trofoblastos/efectos de los fármacos , Adulto , Movimiento Celular/efectos de los fármacos , Células Cultivadas , Vellosidades Coriónicas/fisiología , Técnicas de Cultivo , Ectodermo/metabolismo , Endometrio/citología , Endometrio/metabolismo , Femenino , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Humanos , Embarazo , Primer Trimestre del Embarazo , Receptores CXCR3/genética , Receptores CXCR3/metabolismo , Células del Estroma/citología , Células del Estroma/metabolismo , Trofoblastos/metabolismo
3.
Hum Reprod ; 22(12): 3078-83, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17905749

RESUMEN

BACKGROUND: Limited access to contraception and poor compliance are the major reasons for unintended pregnancy in adolescence. This study was designed to compare knowledge of the combined oral contraceptive pill (COCP) in teenage users and non-users. We speculated that consultations between COCP users and their physicians would dispel misconceptions. METHODS: A cross-sectional survey was undertaken in public clinics affiliated with an academic center. High school-educated female adolescents aged 14-20 years opting for contraception (n = 254) and Israeli physicians (n = 114) specializing in Obstetrics, Gynecology and Reproductive Endocrinology participated in the study. Information about past or present COCP use and views of the COCP were recorded by employing a ten-question YES/NO self-completion questionnaire, designed by the researchers. RESULTS: The prevalence of incorrect beliefs was exceedingly high in the whole adolescent study group and relatively high among the physicians. The prevalence of incorrect beliefs was comparable between COCP users and non-users, regarding the 10 misconceptions investigated. The duration of COCP use did not influence the prevalence of misconceptions about the pill. Age did not serve as a confounding factor for all misconceptions. CONCLUSIONS: Lack of informative communication between COCP-prescribing physicians and users and mistaken knowledge of the caring physicians may contribute to adolescent ignorance of the COCP. Focusing on adolescent-specific disbeliefs could lead to construction of better educational programs in schools and clinics.


Asunto(s)
Actitud Frente a la Salud , Anticonceptivos Orales Combinados/administración & dosificación , Cooperación del Paciente/psicología , Relaciones Médico-Paciente , Embarazo en Adolescencia/prevención & control , Acné Vulgar/psicología , Adolescente , Adulto , Imagen Corporal , Neoplasias de la Mama/psicología , Anticonceptivos Orales Combinados/efectos adversos , Femenino , Educación en Salud , Humanos , Embarazo , Fumar/psicología , Aumento de Peso
4.
Ultrasound Obstet Gynecol ; 29(3): 352-5, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17274103

RESUMEN

Cornual pregnancy is a rare form of ectopic pregnancy. We describe a case of cornual pregnancy suspected by two-dimensional ultrasonography (2DUS) and confirmed by three-dimensional volume contrast imaging in the C-plane. Three-dimensional power Doppler showed a particularly rich blood supply and two-dimensional color Doppler mapping demonstrated arteriovenous malformation (AVM). The feeding vessel originating from the right uterine artery and AVM were demonstrated with B-flow spatio-temporal image correlation (STIC) modality. Conservative management was chosen to preserve the uterus. Angiography confirmed the diagnosis of AVM; embolization with polyvinyl alcohol particles and embolization coils was performed through the right uterine artery until occlusion of the AVM and feeding vessels had occurred. Postprocedure color Doppler mapping and B-flow STIC modalities demonstrated absence of flow in the AVM. Serum human chorionic gonadotropin (hCG) levels gradually fell to non-pregnant levels during the ensuing 5 weeks. To the best of our knowledge this is the first report of cornual pregnancy with AVM. We demonstrate here the value of new three-dimensional ultrasound modalities in the diagnosis of cornual pregnancy and the use of embolization as an effective therapeutic option when conservative treatment with uterine preservation is desired.


Asunto(s)
Malformaciones Arteriovenosas/diagnóstico por imagen , Imagenología Tridimensional/métodos , Embarazo Ectópico/diagnóstico por imagen , Útero/diagnóstico por imagen , Adulto , Angiografía , Malformaciones Arteriovenosas/terapia , Embolización Terapéutica , Femenino , Humanos , Embarazo , Ultrasonografía Doppler en Color , Ultrasonografía Prenatal/métodos , Útero/irrigación sanguínea
5.
Mol Hum Reprod ; 10(4): 229-35, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-14996996

RESUMEN

Trophoblast invasion, accompanied by degradation of extracellular matrix, is crucial to normal pregnancy development, whereas shallow placental invasion and implantation likely plays a role in the subsequent development of pre-eclampsia. The growth factors vascular endothelial growth factor (VEGF), epidermal growth factor (EGF) and fibroblast growth factor (FGF) are placental growth factors that activate degradation of extracellular matrix. We determined the effect of VEGF, EGF, FGF-2, FGF-4 and FGF-10 on the plasminogen activator system of first trimester cytotrophoblasts cultured in vitro. We studied the activity of urokinase plasminogen activator (uPA), its inhibitor plasminogen activator inhibitor-1 (PAI-1), and 92 kDa gelatinase-B (matrix metalloproteinase-9, MMP-9), using protein gel and reversed gel zymography. The expression pattern of FGF-4 and FGF-10 in human placental sections was determined by immunohistochemistry. FGF-4 was expressed in first trimester villi stroma, primarily in endothelial cells. FGF-10 expression was localized to first trimester extravillous trophoblasts. VEGF, EGF, FGF-4 and FGF-10, but not FGF-2, stimulate the activity of trophoblast uPA, PAI-1 and MMP-9. These results support the hypothesis that specific growth factors modulate the invasive potential of trophoblasts, and therefore may play an important role in early placental development. Our findings may contribute to the understanding of the pathophysiology of diseases associated with shallow placentation, such as pre-eclampsia.


Asunto(s)
Factor de Crecimiento Epidérmico/metabolismo , Factores de Crecimiento de Fibroblastos/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Trofoblastos/metabolismo , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismo , Femenino , Factor 10 de Crecimiento de Fibroblastos , Factor 2 de Crecimiento de Fibroblastos/metabolismo , Factor 4 de Crecimiento de Fibroblastos , Humanos , Inmunohistoquímica , Inhibidor 1 de Activador Plasminogénico/metabolismo , Embarazo
6.
J Am Assoc Gynecol Laparosc ; 10(2): 200-4, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12732772

RESUMEN

STUDY OBJECTIVE: To assess obstetric performance and fetal outcomes after laparoscopy or laparotomy performed during pregnancy. DESIGN: Nationwide, multicenter, retrospective chart review (Canadian Task Force classification II-2). SETTING: Seventeen hospitals throughout Israel: 12 university or university-affiliated hospitals and 5 general hospitals. PATIENTS: Three hundred eighty-nine pregnant women. INTERVENTION: Laparoscopy or laparotomy for various indications. MEASUREMENTS AND MAIN RESULTS: Of 192 laparoscopies performed, 141 were during the first, 46 during the second, and 5 during the third trimester; respective figures for 197 laparotomies were 63, 110, and 24. No intraoperative complications were reported for either procedure. Six and 25 women had complications after laparoscopy and laparotomy, respectively. There was no significant difference in abortion rates between groups. Mean gestational age at delivery and mean birthweight were comparable between groups. No significant difference was found in frequency of fetal anomalies between groups or when compared with the Israel register of anomalies. CONCLUSION: Operative laparoscopy seems to be as safe as laparotomy in pregnancy.


Asunto(s)
Laparoscopía/métodos , Laparotomía/métodos , Complicaciones Posoperatorias/epidemiología , Complicaciones del Embarazo/cirugía , Resultado del Embarazo , Adulto , Femenino , Edad Gestacional , Humanos , Incidencia , Israel , Laparoscopía/efectos adversos , Laparotomía/efectos adversos , Embarazo , Probabilidad , Estudios Retrospectivos , Medición de Riesgo , Sensibilidad y Especificidad , Resultado del Tratamiento
7.
Ultrasound Obstet Gynecol ; 21(3): 302-5, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12666229

RESUMEN

Supraventricular tachycardia (SVT) is the most commonly encountered clinically significant tachycardia in the fetus. When SVT is sustained, congestive heart failure and fetal hydrops may ensue, due to both systolic and diastolic dysfunction. Sonographic diagnosis is usually incidental during the second or third trimester. Treatment goals are cardioversion to sinus rhythm and reversal of cardiac dysfunction. We describe a case of fetal SVT diagnosed at 13 weeks of gestation. Treatment with digoxin and flecainide was successful; the heart rate returned to sinus rhythm within one day, and fetal hydrops resolved within 8 days of treatment. We suspect that as more first-trimester examinations are performed, more cases with SVT will be diagnosed. We discuss the treatment protocol, and suggest that co-administration of two drugs that act synergistically may be more efficient than monotherapy, which is currently used as the first line of treatment. In addition, we discuss the potentially deleterious effect of heart failure encountered at an early developmental stage on the central nervous system. More data need to be collected in order to substantiate a clear recommendation regarding optimal management.


Asunto(s)
Hidropesía Fetal/complicaciones , Taquicardia Supraventricular/diagnóstico por imagen , Adulto , Antiarrítmicos/uso terapéutico , Digoxina/uso terapéutico , Femenino , Flecainida/uso terapéutico , Edad Gestacional , Humanos , Hidropesía Fetal/diagnóstico por imagen , Hidropesía Fetal/tratamiento farmacológico , Embarazo , Taquicardia Supraventricular/complicaciones , Taquicardia Supraventricular/tratamiento farmacológico , Ultrasonografía Doppler
8.
Ultrasound Obstet Gynecol ; 21(1): 72-4, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12528167

RESUMEN

Nonne-Milroy lymphedema is a relatively rare disorder characterized by firm edema of the lower extremities either on the whole leg or limited to the feet or toes. We report a case of atypical Nonne-Milroy syndrome that presented prenatally with bilateral leg edema, bilateral hydrothorax and lung hypoplasia at 22 weeks' gestation. The differential diagnoses are discussed.


Asunto(s)
Enfermedades Fetales/diagnóstico por imagen , Linfedema/diagnóstico por imagen , Ultrasonografía Prenatal , Adulto , Edema/diagnóstico por imagen , Femenino , Enfermedades Fetales/genética , Humanos , Pierna , Linfedema/genética , Linaje , Derrame Pleural/diagnóstico por imagen , Embarazo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA